| Source: |
| Type: |
| Various antioxidants such as Nrf2, SODs, catalase, GPxs, PRDXs, and GSTs are altered in different cancers and have been linked to prognosis. Their overexpression can correlate with aggressive tumor behavior and resistance to treatment in many contexts. |
| 4619- | Bor, | Using Boron Supplementation in Cancer Prevention and Treatment: A Review Article |
| - | Review, | Var, | NA |
| 2772- | Bos, | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
| - | Review, | AD, | NA |
| 5711- | Brut, | Citrus bergamia powder: Antioxidant, antimicrobial and anti-inflammatory properties |
| - | in-vitro, | Nor, | HMEC |
| 6549- | BSB, | (-)-α-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice |
| - | in-vivo, | Nor, | NA |
| 6550- | BSB, | α-bisabolol β-D-fucopyranoside as a potential modulator of β-amyloid peptide induced neurotoxicity: An in vitro &in silico study |
| - | in-vivo, | AD, | NA |
| 6542- | BSB, | Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol |
| - | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
| 6552- | BSB, | Biochemical characterization of chamomile essential oil: Antioxidant, antibacterial, anticancer and neuroprotective activity and potential treatment for Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| - | in-vivo, | Nor, | NA |
| 6556- | BSB, | A Comprehensive Study of Therapeutic Applications of Chamomile |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| - | in-vivo, | Nor, | NA |
| 1650- | CA, | Adjuvant Properties of Caffeic Acid in Cancer Treatment |
| - | Review, | Var, | NA |
| 7516- | CA, | Caffeic Acid, a Polyphenolic Micronutrient Rescues Mice Brains against Aβ-Induced Neurodegeneration and Memory Impairment |
| - | in-vivo, | AD, | NA |
| 5756- | CA, | Experimental Evidence of Caffeic Acid’s Neuroprotective Activity in Alzheimer’s Disease: In Vitro, In Vivo, and Delivery-Based Insights |
| - | vitro+vivo, | AD, | NA |
| 5751- | CA, | Potential Therapeutic Implications of Caffeic Acid in Cancer Signaling: Past, Present, and Future |
| - | Review, | Var, | NA |
| 5875- | CA, | Carnosic acid prevents dextran sulfate sodium-induced acute colitis associated with the regulation of the Keap1/Nrf2 pathway |
| - | in-vivo, | IBD, | NA |
| 5834- | CAP, | Capsaicin and TRPV1: A Novel Therapeutic Approach to Mitigate Vascular Aging |
| - | Study, | Nor, | NA |
| 5861- | CAP, | Anticancer Properties of Capsaicin Against Human Cancer |
| - | Review, | Var, | NA |
| 5858- | CAP, | Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 5854- | CAP, | Pharmacological activity of capsaicin: Mechanisms and controversies (Review) |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 5202- | CAP, | Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways |
| - | vitro+vivo, | Bladder, | 5637 | - | in-vitro, | Bladder, | T24/HTB-9 |
| 2019- | CAP, | Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer |
| - | Review, | Var, | NA |
| 5768- | CAPE, | Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 5766- | CAPE, | A Nano-Liposomal Formulation of Caffeic Acid Phenethyl Ester Modulates Nrf2 and NF-κβ Signaling and Alleviates Experimentally Induced Acute Pancreatitis in a Rat Model |
| - | in-vivo, | Nor, | NA |
| - | NA, | HCC, | NA |
| 5758- | CAPE, | PBG, | Caffeic acid phenethyl ester and therapeutic potentials |
| - | Review, | Var, | NA |
| 5887- | CAR, | TV, | Antitumor Effects of Carvacrol and Thymol: A Systematic Review |
| - | Review, | Var, | NA |
| 5881- | CAR, | Carvacrol—A Natural Phenolic Compound with Antimicrobial Properties |
| - | Review, | Nor, | NA |
| 5888- | CAR, | Therapeutic application of carvacrol: A comprehensive review |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | Diabetic, | NA | - | Review, | Park, | NA |
| 5907- | CAR, | Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2 |
| - | in-vitro, | Liver, | HepG2 |
| 5896- | CAR, | TV, | Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics |
| - | Review, | Var, | NA |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 5898- | CAR, | Carvacrol-induced apoptosis via tumor suppressor gene activation and oxidative stress modulation in a rat model of breast cancer |
| - | in-vivo, | BC, | NA |
| 5890- | CAR, | Carvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways |
| - | Review, | Var, | NA |
| 5927- | CAR, | Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 5932- | CAR, | Carvacrol attenuates mucosal barrier impairment and tumorigenesis by regulating gut microbiome |
| - | in-vivo, | IBD, | NA | - | in-vivo, | Park, | NA |
| 5926- | CAR, | An Updated Review of Research into Carvacrol and Its Biological Activities |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | asthmatic, | NA |
| 5925- | CAR, | Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| - | in-vitro, | AD, | NA |
| 3877- | Carno, | Carnosine, diabetes and Alzheimer's disease |
| - | Review, | AD, | NA |
| 3878- | Carno, | Safety and Efficacy Evaluation of Carnosine, An Endogenous Neuroprotective Agent for Ischemic Stroke |
| - | in-vivo, | Stroke, | NA |
| 3872- | Carno, | Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress |
| - | in-vitro, | AD, | NA |
| 3869- | Carno, | Carnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 5938- | Cela, | Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application |
| - | Review, | Var, | NA |
| 6662- | Cen, | Assessment report on Centella asiatica (L.) Urban, herba |
| - | Review, | Nor, | NA |
| 6656- | Cen, | Recent insights into therapeutic potential and nanostructured carrier systems of Centella asiatica: An evidence-based review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6655- | Cen, | Centella asiatica improves cognitive function and alters the hippocampal metabolome of aged Tg2576 and wild-type mice |
| - | in-vivo, | AD, | NA |
| 6647- | Cen, | Protective effects of Centella asiatica extract on spatial memory and learning deficits in animal model of systemic inflammation induced by lipopolysaccharide |
| - | in-vivo, | AD, | NA |
| 6648- | Cen, | Centella asiatica (L.) Urban: From Traditional Medicine to Modern Medicine with Neuroprotective Potential |
| - | Review, | AD, | NA |
| 6022- | CGA, | Chlorogenic Acid: Recent Advances on Its Dual Role as a Food Additive and a Nutraceutical against Metabolic Syndrome |
| - | Review, | Nor, | NA |
| 6021- | CGA, | Chlorogenic acid for cancer prevention and therapy: Current status on efficacy and mechanisms of action |
| - | in-vitro, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1103 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid